Medicina clinica · 2013
[Resting heart rate and cardiovascular disease].
Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Brito Díaz Buenaventura, Alemán Sánchez José Juan, Cabrera de León Antonio
Аннотация
Heart rate reflects autonomic nervous system activity. Numerous studies have demonstrated that an increased heart rate at rest is associated with cardiovascular morbidity and mortality as an independent risk factor. It has been shown a link between cardiac autonomic balance and inflammation. Thus, an elevated heart rate produces a micro-inflammatory response and is involved in the pathogenesis of endothelial dysfunction. In turn, decrease in heart rate produces benefits in congestive heart failure, myocardial infarction, atrial fibrillation, obesity, hyperinsulinemia, insulin resistance, and atherosclerosis. Alteration of other heart rate-related parameters, such as their variability and recovery after exercise, is associated with risk of cardiovascular events. Drugs reducing the heart rate (beta-blockers, calcium antagonists and inhibitors of If channels) have the potential to reduce cardiovascular events. Although not recommended in healthy subjects, interventions for reducing heart rate constitute a reasonable therapeutic goal in certain pathologies.
Предметные рубрики MeSH
Adrenergic beta-AntagonistsAutonomic Nervous SystemCalcium Channel BlockersCardiovascular DiseasesClinical Trials as TopicCohort StudiesDiabetes Mellitus, Type 2Disease SusceptibilityFatty Acids, Omega-3Heart Conduction SystemHeart RateHumansInflammationInsulin ResistanceMyocardiumObesity, AbdominalOxygen ConsumptionPrognosisRestRisk Factors